Authors


Frank J. Weinstock, MD, FACS

Latest:

‘Nothing more can be done' may be shortsighted view

No physician has the ultimate knowledge and should not be afraid to engage colleagues in the treatment of a patient. Usually, the patient will appreciate the concern and will continue as a patient.


Laird Harrison, CPT

Latest:

EyeMDs facing opportunities, challenges for glaucoma innovation

Ophthalmologists must change the way they use data in order to meet the mounting challenges facing their profession, said Paul P. Lee, MD, JD, in the Drs. Henry and Frederick Sutro Memorial Lecture at the 4th Annual Glaucoma 360 New Horizons Forum.


Eugene B. McLaurin, MD

Latest:

Anti-allergic agent alcaftadine stronger in relief of ocular itching

In head-to-head clinical assessments, alcaftadine was found to be statistically and clinically superior to olopatadine for relief of allergic conjunctivitis.



Zack Oakey, MD

Latest:

OD-performed surgery unacceptable, dangerous

In his latest blog, Zack Oakey, MD, writes why he now believes OD-performed procedures should not be legal.


Joy Gibb, ABOC

Latest:

Tips to get more bang for your buck and increase referrals

There are essential components to a budget for your practice-rent, utilities, and staff wages to name a few. But there should also be another section in your budget for marketing.


Donna Suter

Latest:

Patient expectations can blossom in four summer-friendly steps

Tending to an angry ophthalmic customer is the golden opportunity to foster a better relationship with him or her-here's how.



David Gersztenkorn, MD, MS

Latest:

Seeing through the static

Visual snow is a persistent visual disturbance that is typically described as seeing ‘television static’ throughout the visual field.


Timothy A. Walline, MD

Latest:

Femtosecond lasers useful tool in certain stages of Fuchs dystrophy

Ophthalmologists are finding that femtosecond laser-assisted cataract surgery may be beneficial to some patients with Fuch’s dystrophy.


Alan B. Aker, MD

Latest:

Why the femto-cataract business model works

For the Aker Kasten Eye Center, the surgical benefits of switching to femtosecond laser cataract surgery have surpassed any initial financial concerns.


Martin J. Fox, MD, FACS

Latest:

Intrastromal rings for keratoconus

Take-home message: Implantation of intrastromal rings for keratoconus can be a highly effective treatment with proper patient screening, surgical planning, and femtosecond laser precision.


Faye Emery

Latest:

Presbyopia compensation with femtosecond laser

This article discusses the advantages and limitations for surgical compensation of presbyopia with the femtosecond laser using corneal inlays and the Intracor technique.


Mark Packer, MD, FACS, CPI

Latest:

Pearls and pitfalls for principal investigators

Interested in becoming a principal researcher? Read this first.


Jonathan D. Solomon, MD

Latest:

Laser cataract surgery favored over phaco for reducing ultrasonic energy use

The Laser Cataract Consortium, comprising five experienced laser cataract surgeons, undertook a study incorporating rigorous collection of data from 7,200 eyes undergoing cataract surgery.


Lisa Heckler, MD

Latest:

Evidence supports cataract surgery for IOP control in exfoliation syndrome

Cataract surgery lowers IOP in eyes with exfoliation syndrome (XFS) or exfoliation glaucoma (XFG), and it might even change the natural history of glaucoma in eyes with XFS. However, it may also be appropriate to combine phacoemulsification with glaucoma surgery in certain patients with XFG.


Matthew D. Paul, MD

Latest:

Amlodipine, marginal pupil dilation link explored in study

A calcium channel blocker may be associated with marginal pupil dilation, making it more likely that pupil-dilating devices will be needed during phacoemulsification.


Francesca Harman, MD

Latest:

The Importance of the Ocular Surface to Surgical Results

Learn about the effect of increased osmolarity on the corneal surface. This video provides insight into managing patients with hyperosmolarity and about the importance of testing in patients considering surgery.


Angelo P. Tanna

Latest:

Glaucoma therapy: What if a PGA isn’t enough?

In this article, Dr Tanna discusses treatment options for glaucoma patients who do not show satisfactory response to a PGA while taking into consideration the two key therapeutic choice factors: IOP-lowering efficacy and tolerability.


Svetlana Anisimova, MD, PhD

Latest:

Laser-assisted procedure brings ease, precision & safety to deep sclerectomy

CO2 laser-assisted sclerectomy surgery performed with a proprietary platform offers an effective and safer alternative to the manual non-penetrating deep sclerectomy procedure for the management of medically uncontrolled open-angle glaucoma.


Tamer A. Macky, FRCSEd

Latest:

Fixed combination therapy in glaucoma patients

In this comparison study, IOP reductions were greater with BTFC than with TTFC and patients on this combination were more likely to achieve and maintain low target pressures. Combined BrTFC and DTFC may also be a more appropriate therapeutic choice for IOP lowering than TTFC and BrTFC, respectively.


Ralph Chu, MD

Latest:

Corneal inlay for presbyopia shows promise without added visual problems in pseudophakes

The Raindrop Near Vision Inlay (Revision Optics) improves near-visual performance without added visual disturbance in pseudophakic patients.


Peter W. Stalmans, MD

Latest:

Ocriplasmin success based on proper patient selection

Real-world experience with ocriplasmin indicates it is an effective, safe, and cost-effective treatment for symptomatic vitreomacular adhesion in properly selected eyes.


Lisa Stewart

Latest:

Retinal prosthetic device beneficial for blind patients with retinitis pigmentosa

Patients who are blind from retinitis pigmentosa continue to benefit from a safe retinal implant after 3 years, Ophthalmology reported


Kuan-Hui Hsu

Latest:

Combination glaucoma therapy by drug-eluting lenses

In this article, the authors present their recent findings on drug-eluting, extended-wear contact lenses for glaucoma and discuss how these lenses may provide week-long IOP reduction with just one day of wear.


Svein Erik Thomassen

Latest:

Real-world experience with the MFR2 IOL

Dr Thomassen shares his personal experiences with the MFR2 IOL, including reasons why the MFR2 is his lens of preference, clinical findings from a real-life setting and considerations for future use.


Paolo Lanzetta, MD

Latest:

Advice on choosing AREDS or AREDS 2 in non-smokers

In this article, the authors discuss the benefits of nutritional supplementation in preventing AMD progression and consider which AREDS formulation is the most appropriate in smokers and non-smokers.


Tsontcho Sean Ianchulev, MD, MPH

Latest:

Small drop delivers big advancement

The piezo-print microdosing delivers drugs in less than 80 milliseconds, beating the eye’s 100-millisecond reflex.


Gábor Holló, MD, PhD, DSc

Latest:

Tips to best manage exfoliative glaucoma

Exfoliative glaucoma can prove to be a particularly difficult disease for opthalmologists to manage. In this article, aspects of IOP-lowering therapy specific to this type of glaucoma are considered, as well as the range of treatments available and the potential advantages and challenges associated with each therapy.


Daniele Veritti, MD

Latest:

Advice on choosing AREDS or AREDS 2 in non-smokers

In this article, the authors discuss the benefits of nutritional supplementation in preventing AMD progression and consider which AREDS formulation is the most appropriate in smokers and non-smokers.

© 2024 MJH Life Sciences

All rights reserved.